C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/01 (2006.01) A01N 63/00 (2006.01) A61K 31/711 (2006.01) A61K 35/76 (2006.01) A61K 48/00 (2006.01) C07K 14/075 (2006.01) C12N 7/00 (2006.01) C12N 7/04 (2006.01)
Patent
CA 2449013
Oncolytic viruses are described that have favorable anti-cancer activity and that are produced by random mutagenesis and subsequent bio-selection on cancer cells wherein the viruses are preferably adenoviruses having at least one mutation in the i-leader sequence of the viral major late transcriptional unit.
L'invention se rapporte à des virus oncolytiques qui présentent une activité anticancéreuse positive et qui sont produits par mutagenèse aléatoire et par bio-sélection ultérieure sur des cellules cancéreuses, ces virus étant de préférence des adénovirus présentant au moins une mutation dans la séquence de tête i de la dernière et principale unité de transcription virale.
Fattaey Ali
Hermiston Terry
Shen Yuqiao
Fetherstonhaugh & Co.
Onyx Pharmaceuticals Inc.
LandOfFree
Viral mutants that selectively replicate in targeted human... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Viral mutants that selectively replicate in targeted human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral mutants that selectively replicate in targeted human... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1855678